Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-11 Sale | 2024-04-15 7:03 pm | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 6,964 | $24.11 | $167,888 | 203,129 (Indirect Direct) | View |
| 2024-03-19 Sale | 2024-03-21 6:41 pm | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 1,270 | $14.5 | $18,419 | 210,093 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-20 7:41 pm | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 1,270 | $17.42 | $22,117 | 211,363 (Indirect Direct) | View |
| 2024-01-30 Sale | 2024-02-01 8:10 pm | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 1,270 | $16.41 | $20,840 | 212,633 (Indirect Direct) | View |
| 2023-12-21 Sale | 2023-12-26 7:29 pm | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 216 | $13 | $2,808 | 213,903 (Indirect Direct) | View |
| 2023-12-19 Sale | 2023-12-21 4:28 pm | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 4,280 | $13.02 | $55,727 | 214,119 (Indirect Direct) | View |
| 2021-09-14 Sale | 2021-09-16 6:19 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,388 | $25.04 | $34,760 | 228,772 (Indirect Direct) | View |
| 2021-09-10 Sale | 2021-09-14 4:03 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,080 | $25.05 | $27,056 | 230,160 (Indirect Direct) | View |
| 2021-09-07 Sale | 2021-09-09 4:36 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,086 | $25.11 | $27,272 | 231,240 (Indirect Direct) | View |
| 2021-06-01 Sale | 2021-06-02 4:11 pm | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 3,900 | $32.55 | $126,935 | 43,704 (Indirect Direct) | View |
| 2021-05-20 Sale | 2021-05-24 7:30 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 1,400 | $25.15 | $35,208 | 232,326 (Indirect Direct) | View |
| 2021-05-14 Sale | 2021-05-18 8:22 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 5,874 | $25.29 | $148,582 | 233,726 (Indirect Direct) | View |
| 2021-05-11 Sale | 2021-05-13 8:00 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 100 | $25.11 | $2,511 | 239,600 (Indirect Direct) | View |
| 2021-04-28 Sale | 2021-04-30 7:59 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 200 | $25.17 | $5,034 | 239,700 (Indirect Direct) | View |
| 2021-04-01 Sale | 2021-04-05 7:42 pm | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 100 | $25 | $2,500 | 239,900 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-26 Disposition | 2024-02-27 4:59 pm | N/A N/A | RayzeBio Inc. | RYZB | Heyman Richard A. Director | 367,446 | $62.5 | 0 (Direct) | View |
| 2024-02-13 Option Award(A) | 2024-02-20 7:32 pm | N/A 2034-02-13 | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 29,205 | $0 | 29,205 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:52 pm | N/A 2034-02-12 | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 21,043 | $0 | 21,043 (Direct) | View |
Ownership | 2023-09-14 7:26 pm | N/A N/A | RayzeBio Inc. | RYZB | Heyman Richard A. Director | 0 | $0 | 367,446 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:54 pm | N/A 2033-06-13 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 5:39 pm | N/A 2033-06-07 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 21,500 | $0 | 21,500 (Direct) | View |
| 2023-02-23 Option Award | 2023-04-06 8:19 pm | N/A 2033-02-23 | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 34,458 | $0 | 34,458 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 9:54 pm | N/A 2032-08-12 | Enliven Therapeutics Inc. | ELVN | Heyman Richard A. Director | 239,056 | $0 | 201,649 (Direct) | View |
| 2022-05-18 Option Award | 2022-09-06 7:23 pm | N/A 2032-05-17 | Metacrine Inc. | MTCR | Heyman Richard A. Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 5:32 pm | N/A 2032-06-16 | Gritstone bio Inc. | GRTS | Heyman Richard A. Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-17 8:22 pm | N/A 2032-06-16 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 53,700 | $0 | 53,700 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:41 pm | N/A 2032-06-01 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 19,500 | $0 | 19,500 (Direct) | View |
| 2021-06-18 Option Award | 2021-11-19 4:57 pm | N/A 2031-06-17 | Gritstone bio Inc. | GRTS | Heyman Richard A. Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-07-23 4:07 pm | N/A 2031-05-11 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 5,781 | $0 | 5,781 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 7:46 pm | N/A 2031-06-15 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 16,625 | $0 | 16,625 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-09 5:30 pm | N/A 2031-06-01 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 16,333 | $0 | 16,333 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:05 pm | N/A 2031-06-01 | YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director | 14,800 | $0 | 14,800 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-02 4:11 pm | N/A 2027-08-16 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 3,900 | $0 | 43,704 (Indirect) | View |
| 2021-06-01 Exercise | 2021-06-02 4:11 pm | N/A N/A | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 2,925 | $2.95 | 43,704 (Indirect) | View |
| 2021-06-01 Exercise | 2021-06-02 4:11 pm | N/A N/A | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 975 | $975 | 43,704 (Indirect) | View |
| 2021-05-24 Option Award | 2021-05-25 7:01 pm | N/A 2031-05-23 | Metacrine Inc. | MTCR | Heyman Richard A. Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 6:38 pm | N/A N/A | YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director | 1,959 | $0 | 8,117 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 7:10 pm | N/A 2030-04-06 | YUMANITY THERAPEUTICS INC. | YMTX | Heyman Richard A. Director | 11,429 | $0 | 11,429 (Direct) | View |
| 2020-11-11 Option Award | 2020-11-12 4:14 pm | N/A 2030-06-22 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 45,332 | $0 | 45,332 (Direct) | View |
Ownership | 2020-09-24 7:12 pm | N/A 2027-08-16 | PMV Pharmaceuticals Inc. | PMVP | Heyman Richard A. Director | 0 | $0 | 244,044 (Direct) | View |
Ownership | 2020-09-16 12:06 pm | N/A N/A | Metacrine Inc. | MTCR | Heyman Richard A. Director | 0 | $0 | 189,019 (Direct) | View |